abstract |
The present invention provides novel β 2 adrenergic receptor agonist compounds. The present invention also includes pharmaceutical compositions containing such compounds, methods of using such compounds to treat diseases associated with β 2 adrenergic receptor activity, and useful for preparing such compounds. New processes and intermediates. The present invention relates to amidine-substituted arylaniline compounds, pharmaceutical compositions containing such compounds, methods of using such compounds, and methods of preparing such compounds. |